The biological plausibility of caffeine's protective role in AD is supported by its ability to antagonize adenosine A2A receptors, which may influence the accumulation of beta-amyloid plaques and neurofibrillary tangles - hallmark pathological features of AD [3]. Here, ADORA2A is linked to Alzheimer disease.